This study, Hypofractionated Radiotherapy in Older Patients with Non-melanoma Skin Cancer: Less is Better, explores how our Xstrahl 300 system was used to successfully treat NMSC for 3 older patients. See the full study here, and more details below.
XBeam V2: FDA-Approved Treatment Planning Software
The Fastest, Safest Way to Plan Superficial & Orthovoltage Treatment XBeam V2 is the revolutionary, FDA 510(k)-cleared dose planning software designed to automate planning, eliminate risk, and seamlessly integrates with the Concerto system, Xstrahl’s clinical...
